CSIMarket
 
Veru Inc   (VERU)
Other Ticker:  
 
 


 
 VERU $0.5800 $-0.0201 -3.35%

 Volume (M): 1,838   Open : 0.61    52 Wk Avg :  0.95

 
 VERU $0.5800 $-0.0201 -3.35%

 Volume (M): 1,838   Open : 0.61    52 Wk Avg :  0.95




VERU Today's High: $0.62 VERU Shares One Week Perf: -11.85 %
VERU Today's Low: $ 0.58 VERU Shares 30 Day Performance: 38.99 %
Number of VERU Shares Traded (M): 1,838 VERU Share Price 52 Wk High: $ 1.78
Value of VERU's Shares Traded (M$): $ 1,066 VERU Share Price 52 Wk Avg: $0.95
Share Price at the Open: $0.61 VERU's Share Price 52 Wk Low: $0.36



  News about Veru Inc's Stock Splits and Dividends

Veru Faces Compliance Concerns as Nasdaq Issues Delinquency Notice

Veru Faces Delinquency Notice from Nasdaq, Highlighting Compliance Issues
MIAMI, FL, Feb. 27, 2024 - Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company, recently received a delinquency notification letter from the Nasdaq Stock Market LLC regarding its failure to file its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023. This non-compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of financial reports with the Securities and Exchange Commission (SEC), has raised concerns among market observers.
The notification letter received on February 21, 2024, highlights Veru's failure to meet Nasdaq's listing requirements. As a result, the company faces potential consequences, including a possible delisting from the Nasdaq Stock Market. This news has undoubtedly created uncertainty among Veru?s investors and stakeholders.

Veru Inc. Raises $33 Million Through Successful Pricing of Common Stock Offering



Veru Inc., a leading late-stage biopharmaceutical company specializing in the development of innovative treatments for metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome, has announced the pricing of its underwritten public offering. The offering consists of 45,833,333 shares of Veru's common stock at a price of $0.72 per share. This move is expected to generate gross proceeds of around $33 million for Veru, excluding underwriting discounts, commissions, and other offering expenses. Furthermore, Veru has granted the underwriters a 30-day option to purchase an additional 6,874,999 shares of common stock. The offering is set to close on or about December 18, 2023, pending customary closing conditions.
Context and Analysis:
To better understand the significance of Veru Inc.'s public offering, it is essential to examine the company's current standing in the stock market. As of the press release, Veru had 84.626320909091 million shares outstanding, and each share was priced at $0.827. This means that the offer price of $0.72 per share represents a slight discount.





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com